-
121
Research progress of HIF-1a on immunotherapy outcomes in immune vascular microenvironment
Published 2025-02-01Subjects: Get full text
Article -
122
-
123
Correction: Silver nanoparticle induced immunogenic cell death can improve immunotherapy
Published 2025-01-01Get full text
Article -
124
CSF3R as a potential prognostic biomarker and immunotherapy target in glioma
Published 2024-06-01Get full text
Article -
125
-
126
Viral and Nonviral Engineering of Natural Killer Cells as Emerging Adoptive Cancer Immunotherapies
Published 2018-01-01“…As effectors of cancer immunotherapy, NK cells are attractive as they do not attack healthy self-tissues nor do they induce T cell-driven inflammatory cytokine storm, enabling their use as allogeneic adoptive cellular therapies. …”
Get full text
Article -
127
Ultrasound‐Activated Precise Sono‐Immunotherapy for Breast Cancer with Reduced Pulmonary Fibrosis
Published 2025-02-01Subjects: Get full text
Article -
128
Crosstalk between Gut Microbiota and Cancer Immunotherapy: Present Investigations and Future Perspective
Published 2025-01-01“…Gut microbiota is crucial for protecting the homeostasis of immune locally and systemically, and its dysbiosis is essentially correlated to tumorigenesis, cancer progression, and refractoriness to cancer treatments, including the novel immunotherapy. Increasing evidence unravel the intricate role of gut microbiota in reshaping tumor microenvironment and affecting the efficacy and toxicities of immunotherapy, which shed more light on the future applications of gut microbiota in efficacious biomarker and combination treatment of immunotherapy. …”
Get full text
Article -
129
Efficacy of natural killer T and gammadelta T cells in mesothelin-targeted immunotherapy of pancreatic cancer
Published 2025-02-01“…Current pancreatic cancer immunotherapy focused on alphabeta (αβ) T cells, either through CD3-engaged bispecific antibodies or CAR-T. …”
Get full text
Article -
130
Disseminated M. bovis Infection and Vertebral Osteomyelitis following Immunotherapy for Bladder Cancer
Published 2020-01-01“…The use of BCG in immunotherapy for bladder cancer has been in practice for over 40 years. …”
Get full text
Article -
131
A Case of Immunotherapy-Induced Colitis Complicated by Perforation and Treated with Infliximab Postoperatively
Published 2019-01-01“…Standard management for those with severe colitis includes administration of systemic corticosteroids with the reservation of antitumor necrosis factor (anti-TNF) therapy, such as infliximab, if there has been no improvement. Rarely, immunotherapy-induced colitis can become life-threatening and result in bowel perforation requiring surgical intervention. …”
Get full text
Article -
132
Uncommon BRAF Mutations Associated with Durable Response to Immunotherapy in Patients with Metastatic Melanoma
Published 2017-01-01“…Currently, it is unknown how patients with BRAF non-V600 mutations respond to immunotherapy. This report will examine the effect of immunotherapy on two distinct metastatic melanoma patients, each with uncommon BRAF mutations, occurring outside the V600 locus (E586K and G469E). …”
Get full text
Article -
133
Immunotherapy for Metastatic Melanoma with Right Atrial Involvement in a Patient with Rheumatoid Arthritis
Published 2017-01-01“…Concerns exist that immunotherapy in these patients could worsen autoimmune disease or increase the risk of developing additional immune-related adverse events on therapy. …”
Get full text
Article -
134
Radiofrequency ablation combined with immunotherapy to treat hepatocellular carcinoma: a comprehensive review
Published 2025-01-01Subjects: Get full text
Article -
135
Engineered biomimetic cisplatin-polyphenol nanocomplex for chemo-immunotherapy of glioblastoma by inducing pyroptosis
Published 2025-01-01Subjects: Get full text
Article -
136
Is immunotherapy protective against steroid intake in patients with polysensitized allergic rhinitis and/or asthma?
Published 2024-11-01Subjects: “…allergen immunotherapy…”
Get full text
Article -
137
Computational biology and artificial intelligence in mRNA vaccine design for cancer immunotherapy
Published 2025-01-01Subjects: Get full text
Article -
138
Butyrate Enhances Desensitization Induced by Oral Immunotherapy in Cow’s Milk Allergic Mice
Published 2019-01-01“…In previous studies, we showed that a fructo-oligosaccharide- (FOS-) supplemented diet enhanced oral immunotherapy (OIT) efficacy in a mouse model for cow’s milk allergy. …”
Get full text
Article -
139
Bibliometric analysis of targeted immunotherapy for osteosarcoma-current knowledge, hotspots and future perspectives
Published 2025-02-01Subjects: Get full text
Article -
140
Peptides as Versatile Regulators in Cancer Immunotherapy: Recent Advances, Challenges, and Future Prospects
Published 2025-01-01Subjects: Get full text
Article